Here are five recent findings and guidelines related to colorectal cancer:
GI & Endoscopy
Robert C. Kurtz, MD, is chief of gastroenterology at the Memorial Sloan Kettering Cancer Center in New York City.
Takeda reached a deal to sell a number of its over-the-counter and prescription pharmaceutical assets to Swiss pharmaceutical company Acino for more than $200 million.
Four GI physicians featured in the news this last week:
Colorectal cancer screening rates have increased since 2008, yet racial and ethnic disparities are still limiting further advancement, according to a study published in Clinical Gastroenterology and Hepatology.
Here are 11 updates from gastroenterology companies and practices from the past week:
Here are five of the top-read GI articles on Becker's ASC Review this week:
Dallas-based GI Alliance entered into a partnership with Phoenix-based Arizona Digestive Health, growing its affiliated network to more than 275 physicians in four states.
More gastroenterologists and insurance companies are beginning to prefer the sedative propofol over traditional sedation for colonoscopies, despite the increased cost, according to a report in The Buffalo News.
Mark Levstik, MB BCh, is the chief of the gastroenterology and hepatology division at the University of Rochester (N.Y.) Medical Center.
